Skip to main content
TipRanks
Go Ultimate75% OFF

CytomX Therapeutics (CTMX) Q4 2023 Earnings Report

1,006 Followers

CTMX Q4 2023 EPS Results

Actual EPS
$0.02
Consensus EPS
-$0.05
Beat/Miss
Beat by +$0.07
One Year Ago EPS
-$0.42

CTMX Q4 2023 Revenue Results

Actual Revenue
$26.61M
Expected Revenue
$19.60M
Beat/Miss
Beat by +$7.01M
YoY Revenue Growth
+32.22%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/11/2024
Time
After Close
Conference Call
Monday, March 11, 2024
CTMX Upcoming Earnings

CytomX Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

CTMX Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CTMX Earnings History

CTMX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)-0.08--0.17――
Nov 05, 20262026 (Q3)-0.07-0.09-0.090.00% (+0.00)
Aug 06, 20262026 (Q2)-0.08-0.090―
May 07, 20262026 (Q1)-0.12-0.100.27-137.04% (-0.37)
Mar 16, 20262025 (Q4)-0.09-0.170.22-178.64% (-0.39)
Nov 06, 20252025 (Q3)-0.05-0.090.07-228.57% (-0.16)
Aug 07, 20252025 (Q2)-0.060.00-0.08100.00% (+0.08)
May 12, 20252025 (Q1)0.130.270.1758.82% (+0.10)
Mar 06, 20252024 (Q4)-0.200.220.021000.00% (+0.20)
Nov 07, 20242024 (Q3)-0.170.070.0475.00% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed